2m 2m 2m 2m 2m 2m 2m
NEURAXIS (NRXS)
NYSE
$7.14-$0.03 (-0.42%)
Price as of Oct 02, 2026 4:10 PM EDT- $90.0MMarket Cap
- 124.76%1-Year Change
- BiotechnologyIndustry
NEURAXIS (NRXS)
$7.14-$0.03 (-0.42%)
NRXS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.17 | ||
Change | -$0.20 (-2.71%) | ||
Open | $7.39 | ||
High | $7.95 | ||
Low | $7.00 | ||
Previous Close | $7.37 | ||
Volume | 134,875 | ||
30-Day Average Volume | 155,984 | ||
1-Week Change | -7.48% | ||
1-Month Change | 23.41% | ||
1-Year Change | 124.76% | ||
3-Year Change | 88.68% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 12.6M | ||
Total Assets | $10.0M | ||
Market Cap | $90.0M | ||
Enterprise Value | $81.9M | ||
Period: QTR TTM FY | |||
Revenue | $1.9M | ||
Net Income | -$2.1M | ||
Free Cash Flow | -$1.0M | ||
EBIT | -$2.1M | ||
EBITDA | -$2.0M | ||
Net Working Capital | $6.3M | ||
EPS | -$0.19 | ||
Enterprise Value/EBITDA | -40 | ||
Enterprise Value/Revenue | 42 | ||
P/B | 13 | ||
P/E | -38 | ||
PEG | 7 | ||
Price/Free Cash Flow | -87 | ||
Price/Operating Cash Flow | -87 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue